Watchman Left Atrial Appendage Closure Device
Baystate Interventional Cardiology now implants the Watchman, Left Atrial Appendage Closure Device, a first-of-its-kind, proven alternative to long-term warfarin therapy for stroke risk reduction in patients with non-Valvular atrial fibrillation (AF).
The Watchman Device is intended for percutaneous, transcatheter closure of the of the left atrial appendage (LAA). By closing off the LAA, a thin, sack-like appendix arising from the left side of the heart that is believed to be the source of the majority of stroke-causing blood clots in people with non-Valvular AF1, the risk of stroke may be reduced and, over time, patients may be able to stop taking warfarin.
Who is appropriate for Watchman?
Patients who may be eligible:
- Are at an increased risk for stroke and systemic embolism based on CHADS2 or CHAD2DS2-VAScscores and are recommended for anticoagulation therapy
- Are deemed by their physicians to be suitable for warfarin
- Have an appropriate rationale to seek non-pharmacologic alternative to warfarin, taking into account the safety and effectiveness of the device compared to warfarin.
Refer a patient: 413-794-4011